title: Malignant hypertension and antiphospholipid antibodies as presenting features of SLE in a young woman using oral contraceptives.
abstract: A 24-year-old woman developed malignant hypertension while on oral contraceptives (OCs). She was found to have incomplete systemic lupus erythematosus (SLE) with DNA antibodies and high levels of antiphospholipid antibodies (APLA). She later developed SLE and has had three miscarriages and a cerebellar infarction.
authors.affiliation: Fourth Department of Medicine, Helsinki University Central Hospital, Finland.
authors.forename: H
authors.initials: H
authors.lastname: Julkunen
authors.forename: R
authors.initials: R
authors.lastname: Kaaja
authors.forename: T
authors.initials: T
authors.lastname: Jouhikainen
authors.forename: A M
authors.initials: AM
authors.lastname: Teppo
authors.forename: C
authors.initials: C
authors.lastname: Friman
mesh_terms: D000328:Adult; D000974:Antibodies, Antinuclear / Q000378:metabolism; D001323:Autoantibodies / Q000378:metabolism*; D004997:Ethinyl Estradiol / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006974:Hypertension, Malignant / Q000139:chemically induced*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000276:immunology; D010743:Phospholipids / Q000276:immunology*
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D010743:Phospholipids; D004997:Ethinyl Estradiol